JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M510954200 on March 30, 2006

J. Biol. Chem., Vol. 281, Issue 22, 15320-15329, June 2, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/22/15320    most recent
M510954200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Hamamori, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Hamamori, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nuclear Rho Kinase, ROCK2, Targets p300 Acetyltransferase*

Toru Tanaka{ddagger}, Dai Nishimura§, Ray-Chang Wu, Mutsuki Amano||, Tatsuya Iso{ddagger}, Larry Kedes**, Hiroshi Nishida{ddagger}{ddagger}, Kozo Kaibuchi||, and Yasuo Hamamori§1

From the §Department of Medicine and Center for Cardiovascular Development and the Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, the ||Department of Cell Pharmacology and Institute for Advanced Research, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan, the {ddagger}Department of Medicine and Biological Science, Gunma University School of Medicine, Maebashi 371-8511, Japan, the **Departments of Biochemistry and Molecular Biology, and Medicine, Institute for Genetic Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California 90089-9075, and the {ddagger}{ddagger}Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima, Niigata 956-8603, Japan

Rho-associated coiled-coil protein kinase (ROCK) is an effector for the small GTPase Rho and plays a pivotal role in diverse cellular activities, including cell adhesion, cytokinesis, and gene expression, primarily through an alteration of actin cytoskeleton dynamics. Here, we show that ROCK2 is localized in the nucleus and associates with p300 acetyltransferase both in vitro and in cells. Nuclear ROCK2 is present in a large protein complex and partially cofractionates with p300 by gel filtration analysis. By immunofluorescence, ROCK2 partially colocalizes with p300 in distinct insoluble nuclear structures. ROCK2 phosphorylates p300 in vitro, and nuclear-restricted expression of constitutively active ROCK2 induces p300 phosphorylation in cells. p300 acetyltransferase activity is dependent on its phosphorylation status in cells, and p300 phosphorylation by ROCK2 results in an increase in its acetyltransferase activity in vitro. These observations suggest that nucleus-localized ROCK2 targets p300 for phosphorylation to regulate its acetyltransferase activity.


Received for publication, October 6, 2005 , and in revised form, March 29, 2006.

* This work was supported in part by Grant 3609 American Heart Association, Texas affiliate, Grant 0455058Y, Muscular Dystrophy Association (to Y. H.), and by the Naito Foundation (to T.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Center for Cardiovascular Development, Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, 506D, Houston, TX 77030. Tel.: 713-798-3088; Fax: 713-798-7437; E-mail: hamamori{at}bcm.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al.
Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 1147 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. A. Knock, Y. Shaifta, V. A. Snetkov, B. Vowles, S. Drndarski, J. P.T. Ward, and P. I. Aaronson
Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery
Cardiovasc Res, February 1, 2008; 77(3): 570 - 579.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. M. Stanley
Insulin-Increased Prolactin Gene Expression Requires Actin Treadmilling: Potential Role for P21 Activated Kinase
Endocrinology, December 1, 2007; 148(12): 5874 - 5883.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Grabocka and P. B. Wedegaertner
Disruption of Oligomerization Induces Nucleocytoplasmic Shuttling of Leukemia-Associated Rho Guanine-Nucleotide Exchange Factor
Mol. Pharmacol., October 1, 2007; 72(4): 993 - 1002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.